Publication

Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. 2013. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol. 24:2506–14. doi:10.1093/annonc/mdt224.

Adamo SH, Cain MS, Mitroff SR. 2013. Self-Induced Attentional Blink: A Cause of Errors in Multiple-Target Search. Psychological Science. 24(12):2569–2574. doi:10.1177/0956797613497970.

Bean MG, Stone J, Moskowitz GB, Badger TA, Focella ES. 2013. Evidence of nonconscious stereotyping of Hispanic patients by nursing and medical students. Nurs Res. 62:362–7. doi:10.1097/NNR.0b013e31829e02ec.

Harris DT. 2013. Umbilical cord tissue mesenchymal stem cells: characterization and clinical applications. Curr Stem Cell Res Ther. 8:394–9. doi:10.2174/1574888x11308050006.

Bell ML, McKenzie JE. 2013. Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures. Psychooncology. 22:1738–47. doi:10.1002/pon.3205.

Nagle RB, Algotar AM, Cortez CC, Smith K, Jones C, Sathyanarayana UG, Yun S, Riley J, Nagy D, Dittamore R, et al. 2013. ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma. Prostate. 73:1233–40. doi:10.1002/pros.22675.

Bowen C, Ju J-H, Lee J-H, Paull TT, Gelmann EP. 2013. Functional activation of ATM by the prostate cancer suppressor NKX3.1. Cell Rep. 4:516–29. doi:10.1016/j.celrep.2013.06.039.

Cooley JH, Quale LM. 2013. Skin cancer preventive behavior and sun protection recommendations. Semin Oncol Nurs. 29:223–6. doi:10.1016/j.soncn.2013.06.008.

Belzer M, Morales M, Jagadish B, Mash EA, Wright SH. 2013. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2. J Pharmacol Exp Ther. 346:300–10. doi:10.1124/jpet.113.203257.

Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. 2013. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. Eur J Pharm Sci. 49:699–711. doi:10.1016/j.ejps.2013.05.012.

Cen B, Mahajan S, Wang W, Kraft AS. 2013. Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1. Cancer Res. 73:3402–11. doi:10.1158/0008-5472.CAN-12-4619.

Zhang J, Chen QM. 2013. Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene. 32:2907–16. doi:10.1038/onc.2012.350.

Miller JA, Lang JE, Ley M, Nagle R, Hsu C-H, Thompson PA, Cordova C, Waer A, Chow H-HS. 2013. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev Res (Phila). 6:577–84. doi:10.1158/1940-6207.CAPR-12-0452.

Woo H-H, Baker T, Laszlo C, Chambers SK. 2013. Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA. Mol Cell Proteomics. 12:1661–77. doi:10.1074/mcp.M112.025288.

Torres MA, Pace TW, Liu T, Felger JC, Mister D, Doho GH, Kohn JN, Barsevick AM, Long Q, Miller AH. 2013. Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B. Cancer. 119:1951–9. doi:10.1002/cncr.28003.

Escalante AM, McGrath RT, Karolak MR, Dorr RT, Lynch RM, Landowski TH. 2013. Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo. Cancer Chemother Pharmacol. 71:1567–76. doi:10.1007/s00280-013-2156-3.

Berglund E, Berglund D, Akcakaya P, Ghaderi M, Daré E, Berggren P-O, Köhler M, Aspinwall CA, Lui W-O, Zedenius J, et al. 2013. Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors. Exp Cell Res. 319:1229–38. doi:10.1016/j.yexcr.2013.03.001.

Lencinas A, Chhun DC, Dan KP, Ross KD, Hoover EA, Antin PB, Runyan RB. 2013. Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart. Dis Model Mech. 6:632–42. doi:10.1242/dmm.010595.

Badger TA, Segrin C, Hepworth JT, Pasvogel A, Weihs K, López AM. 2013. Telephone-delivered health education and interpersonal counseling improve quality of life for Latinas with breast cancer and their supportive partners. Psychooncology. 22:1035–42. doi:10.1002/pon.3101.

Wright LE, Frye JB, Lukefahr AL, Timmermann BN, Mohammad KS, Guise TA, Funk JL. 2013. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J Nat Prod. 76:316–21. doi:10.1021/np300663v.

Cance WG, Kurenova E, Marlowe T, Golubovskaya V. 2013. Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics. Sci Signal. 6:pe10. doi:10.1126/scisignal.2004021.

Bernstein C, Nfonsam V, Prasad AR, Bernstein H. 2013. Epigenetic field defects in progression to cancer. World J Gastrointest Oncol. 5:43–9. doi:10.4251/wjgo.v5.i3.43.

Fritz BG, Roberts SA, Ahmed A, Breci L, Li W, Weichsel A, Brailey JL, Wysocki VH, Tama F, Montfort WR. 2013. Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking. Biochemistry. 52:1568–82. doi:10.1021/bi301570m.

Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, et al. 2013. Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 31(7):895–902. doi:10.1200/jco.2011.40.1174.

Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL, Sindhwani P, et al. 2013. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate. 73:328–35. doi:10.1002/pros.22573.